| Literature DB >> 33163144 |
Xiaoxiang Xu1, Guorong Yan2, Juan Chang1, Ping Wang1, Qingqiang Yin1, Chaoqi Liu1, Qun Zhu3, Fushan Lu4.
Abstract
Deoxynivalenol (DON) is the most common mycotoxin that frequently contaminates human food and animal feed, resulting in intestinal diseases and systemic immunosuppression. Glycyrrhinic acid (GA) exhibits various pharmacological activities. To investigate the protective mechanism of GA for DON-induced inflammation and apoptosis in IPEC-J2 cells, RNA-seq analysis was used in the current study. The IPEC-J2 cells were treated with the control group (CON), 0.5 μg/mL DON, 400 μg/mL GA, and 400 μg/mL GA+0.5 μg/mL DON (GAD) for 6 h. Results showed that 0.5 μg/mL DON exposure for 6 h could induce oxidative stress, inflammation, and apoptosis in IPEC-J2 cells. GA addition could specifically promote the proliferation of DON-induced IPEC-J2 cells in a dose- and time-dependent manner. In addition, GA addition significantly increased Bcl-2 gene expression (P < 0.05) and superoxide dismutase and catalase activities (P < 0.01) and decreased lactate dehydrogenase release, the contents of malonaldehyde, IL-8, and NF-κB (P < 0.05), the relative mRNA abundances of IL-6, IL-8, TNF-α, COX-2, NF-κB, Bax, and caspase 3 (P < 0.01), and the protein expressions of Bax and TNF-α. Moreover, a total of 1576, 289, 1398, and 154 differentially expressed genes were identified in CON vs. DON, CON vs. GA, CON vs. GAD, and DON vs. GAD, respectively. Transcriptome analysis revealed that MAPK, TNF, and NF-κB signaling pathways and some chemokines played significant roles in the regulation of inflammation and apoptosis induced by DON. GA may alleviate DON cytotoxicity via the TNF signaling pathway by downregulating IL-15, CCL5, and other gene expressions. These results indicated that GA could alleviate DON-induced oxidative stress, inflammation, and apoptosis via the TNF signaling pathway in IPEC-J2 cells.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33163144 PMCID: PMC7604610 DOI: 10.1155/2020/5974157
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1Cell viability and status affected by GA and DON. (a) Effects of different GA concentrations on cell viability at different incubation times (n = 6). (b) Effects of 0.5 μg/mL DON and different GA concentrations on cell viability for 6 h incubation (n = 6). (c–f) Effects of GA on LDH release and antioxidant indexes in DON-induced cells (n = 3). DON: the single DON (0.5 μg/mL) group; GA: the single GA (400 μg/mL) group; GA+DON: 400 μg/mL GA+0.5 μg/mL DON group. ∗∗P < 0.01 indicates the significant difference, compared with the control group; #P < 0.05 and ##P < 0.01 indicate the significant difference, compared with the DON group; “ns” indicates the insignificant difference, compared with the DON group.
Figure 2GA alleviating cytotoxicity of DON-induced IPEC-J2 cells. (a) Flow cytometry analysis of Annexin V/FITC/PI staining cells; LACR, NCR, VCR, and EACR represent the late apoptotic cell rates, necrotic cell rates, viable cell rates, and early apoptotic cell rates, respectively. (b) Quantification of the total cell apoptotic rates (early apoptotic cell rates+late apoptotic cell rates). (c) Quantification and analysis of the late apoptotic cell rates, necrotic cell rates, viable cell rates, and early apoptotic cell rates in four groups. DON: the single DON (0.5 μg/mL) group; GA: the single GA (400 μg/mL) group; GA+DON: 400 μg/mL GA+0.5 μg/mL DON group. ∗∗P < 0.01 indicates the significant difference, compared with the control group; #P < 0.05 and ##P < 0.01 indicate the significant difference, compared with the DON group.
Figure 3GA alleviating IPEC-J2 cell apoptosis and inflammation induced by DON. (a) The contents of IL-8, caspase 3, and NF-κB. (b) Effects of GA on regulating the relative mRNA abundances of apoptotic and inflammatory genes in DON-induced IPEC-J2 cells. (c) The relative protein expressions of Bax and TNF-α in four groups. DON: the single DON (0.5 μg/mL) group; GA: the single GA (400 μg/mL) group; GA+DON: 400 μg/mL GA+0.5 μg/mL DON group. ∗P < 0.05 and ∗∗P < 0.01 indicate the significant difference, compared with the control group; #P < 0.05 and ##P < 0.01 indicate the significant difference, “ns” indicates P > 0.05, compared with the DON group.
Figure 4Differentially expressed genes (DEGs) profiling by RNA-seq analysis. (a) Principal component analysis of 12 sample relationships. (b) The DEG number of upregulated and downregulated genes in the comparison between different treatment groups. (c) Hierarchical clustering and heat map of DEGs. (d) Venn diagrams of DEGs. CON: control group; DON: the single DON (0.5 μg/mL) group; GA: the single GA (400 μg/mL) group; GAD: 400 μg/mL GA+0.5 μg/mL DON group.
The summary of 63 coexpressed DEGs in CON vs. DON and DON vs. GAD.
| Gene ID | Gene name | Full names of genes | CON vs. DON | CON vs. GA | CON vs. GAD | DON vs. GAD |
|---|---|---|---|---|---|---|
| ENSSSCG00000029311 | MYPN | Myopalladin | Up | Down | — | Down |
| ENSSSCG00000006051 | CTHRC1 | Collagen triple helix repeat containing 1 | Up | Down | Down | Down |
| ENSSSCG00000011972 | FILIP1L | Filamin A interacting protein 1 like | Up | Down | — | Down |
| ENSSSCG00000008648 | RSAD2 | Radical S-adenosyl methionine domain containing 2 | Up | Down | Down | Down |
| ENSSSCG00000035420 | HES4 | Hes family bHLH transcription factor 4 | Up | Down | Down | Down |
| ENSSSCG00000029849 | S1PR1 | Sphingosine-1-phosphate receptor 1 | Up | — | — | Down |
| ENSSSCG00000040359 | GOLGA7B | Golgin A7 family member B | Up | — | Up | Down |
| ENSSSCG00000009789 | HCAR1 | Hydroxycarboxylic acid receptor 1 | Up | — | — | Down |
| ENSSSCG00000025245 | ARMC5 | Armadillo repeat containing 5 | Up | — | — | Down |
| ENSSSCG00000025134 | FAM171B | Family with sequence similarity 171 member B | Up | — | Down | Down |
| ENSSSCG00000040575 | ISG15 | ISG15 ubiquitin-like modifier | Up | — | — | Down |
| ENSSSCG00000009051 | IL-15 | Interleukin 15 | Up | — | — | Down |
| ENSSSCG00000017705 | CCL5 | C-C motif chemokine ligand 5 | Up | — | — | Down |
| ENSSSCG00000021944 | RAC2 | Rac family small GTPase 2 | Up | — | — | Down |
| ENSSSCG00000011195 | GALNT15 | Polypeptide N-acetylgalactosaminyltransferase 15 | Up | — | Up | Down |
| ENSSSCG00000024158 | ANO1 | Anoctamin 1 | Up | — | — | Down |
| ENSSSCG00000021027 | PGBD5 | PiggyBac transposable element-derived 5 | Up | — | — | Down |
| ENSSSCG00000027911 | LTB4R | Leukotriene B4 receptor | Up | — | — | Down |
| ENSSSCG00000009100 | TNIP3 | TNFAIP3-interacting protein 3 | Up | — | Up | Down |
| ENSSSCG00000017277 | PECAM1 | Platelet and endothelial cell adhesion molecule 1 | Up | — | Up | Down |
| ENSSSCG00000034870 | — | — | Up | — | — | Down |
| ENSSSCG00000033093 | RGS6 | Regulator of G protein signaling 6 | Up | — | — | Down |
| ENSSSCG00000026890 | GALNT6 | Polypeptide N-acetylgalactosaminyltransferase 6 | Up | — | — | Down |
| ENSSSCG00000031262 | TXNIP | Thioredoxin-interacting protein | Up | — | Up | Down |
| ENSSSCG00000003080 | — | — | Up | — | — | Down |
| ENSSSCG00000001916 | INSYN1 | Inhibitory synaptic factor 1 | Up | — | — | Down |
| ENSSSCG00000029438 | SESN2 | Sestrin 2 | Down | Up | — | Up |
| ENSSSCG00000035895 | JDP2 | Jun dimerization protein 2 | Down | Up | — | Up |
| ENSSSCG00000039761 | MYCL | MYCL protooncogene, bHLH transcription factor | Down | Up | — | Up |
| ENSSSCG00000022649 | SLC7A11 | Solute carrier family 7 member 11 | Down | Up | — | Up |
| ENSSSCG00000038521 | CHAC1 | ChaC glutathione-specific gamma-glutamylcyclotransferase 1 | Down | Up | — | Up |
| ENSSSCG00000021232 | SYNC | Syncoilin, intermediate filament protein | Down | Up | — | Up |
| ENSSSCG00000023749 | — | — | Down | Up | — | Up |
| ENSSSCG00000008153 | SLC9A2 | Solute carrier family 9 member A2 | Down | — | — | Up |
| ENSSSCG00000033059 | CASKIN1 | CASK-interacting protein 1 | Down | — | Down | Up |
| ENSSSCG00000002778 | ZDHHC1 | Zinc finger DHHC-type containing 1 | Down | — | — | Up |
| ENSSSCG00000016873 | NIM1K | NIM1 serine/threonine protein kinase | Down | — | Down | Up |
| ENSSSCG00000011293 | POMGNT2 | Protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-) | Down | — | — | Up |
| ENSSSCG00000007486 | CYP24A1 | Cytochrome P450, family 24, subfamily A, polypeptide 1 | Down | — | Down | Up |
| ENSSSCG00000029662 | RASSF4 | Ras association domain family member 4 | Down | — | — | Up |
| ENSSSCG00000003848 | LRP8 | LDL receptor-related protein 8 | Down | — | Down | Up |
| ENSSSCG00000025992 | ENPP3 | Ectonucleotide pyrophosphatase/phosphodiesterase 3 | Down | — | — | Up |
| ENSSSCG00000027877 | TLR10 | Toll-like receptor 10 | Down | — | — | Up |
| ENSSSCG00000016562 | SSMEM1 | Serine-rich single-pass membrane protein 1 | Down | — | — | Up |
| ENSSSCG00000038026 | RAB12 | RAB12, member RAS oncogene family | Down | — | — | Up |
| ENSSSCG00000034863 | PARD6A | Par-6 family cell polarity regulator alpha | Down | — | Down | Up |
| ENSSSCG00000011330 | NBEAL2 | Neurobeachin-like 2 | Down | — | Down | Up |
| ENSSSCG00000011949 | CEP97 | Centrosomal protein 97 | Down | — | — | Up |
| ENSSSCG00000014437 | PPARGC1B | PPARG coactivator 1 beta | Down | — | — | Up |
| ENSSSCG00000035969 | THRA | Thyroid hormone receptor alpha | Down | — | — | Up |
| ENSSSCG00000036172 | SP9 | Sp9 transcription factor | Down | — | Down | Up |
| ENSSSCG00000035876 | ZNF599 | Zinc finger protein 599 | Down | — | — | Up |
| ENSSSCG00000024759 | — | — | Down | — | — | Up |
| ENSSSCG00000011915 | GRAMD1C | GRAM domain containing 1C | Down | — | — | Up |
| ENSSSCG00000026849 | CCNO | Cyclin O | Down | — | — | Up |
| ENSSSCG00000003423 | DRAXIN | Dorsal inhibitory axon guidance protein | Down | — | — | Up |
| ENSSSCG00000008227 | ST3GAL5 | ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Down | — | — | Up |
| ENSSSCG00000031321 | NR4A1 | Nuclear receptor subfamily 4 group A member 1 | Down | — | — | Up |
| ENSSSCG00000008413 | GPR75 | G protein-coupled receptor 75 | Down | — | — | Up |
| ENSSSCG00000005673 | IER5L | Immediate early response 5 like | Down | — | — | Up |
| ENSSSCG00000016420 | INSIG1 | Insulin-induced gene 1 | Down | — | Down | Up |
| ENSSSCG00000037391 | — | — | Down | — | — | Up |
| ENSSSCG00000007491 | MC3R | Melanocortin 3 receptor | Down | — | — | Up |
Note: CON: control group; DON: the single DON (0.5 μg/mL) group; GA: the single GA (400 μg/mL) group; GAD: 400 μg/mL GA+0.5 μg/mL DON group.
Figure 5Functional annotation and pathway enrichment results. (a) Gene Ontology (GO) annotation of DEGs in four different comparisons. The top 10 functional classified GO terms of DEGs annotated by the subontology of GO analysis including biological processes (BP), molecular function (MF), and cellular components (CC). (b, c) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment of DEGs for four different comparisons. (b) Top 10 classifications regarding different KEGG pathways. (c) Scatterplot of top 20 pathways in KEGG enrichment.
Figure 6Protein-protein interaction (PPI) network construction of DEGs. (a) The PPI network of DEGs identified from CON vs. DON. (b) The top 30 highly connected DEGs with 19 edges of the PPI network and the top 2 significant modules extracted from the PPI network (MCODE scores are 15 and 13). (c) PPI network constructed from 79 coexpressed genes between CON vs. DON and DON vs. GAD. Red represents gene expression upregulated, and blue represents gene expression downregulated in (a) and (b). Node size indicates the number of genes interacted in (a) and (c). Line thickness indicates the strength of data support in (c). The interaction score was set to 0.9 in (a) and (b) and 0.4 for (c).
Figure 7A proposed model of the protective mechanism of GA against the damage induced by mycotoxin exposure in intestinal epithelial cells of pigs.